Gastrointestinal Stromal Tumors: Study May Result In More Targeted Drugs
Sunday, November 23, 2008 - 17:28
in Health & Medicine
There is strong evidence that patients can have varying clinical responses to medications depending on the specific makeup of their cancer. A new study which focused on gastrointestinal stromal tumors, also called GIST, found that the genetic variations in their disease appear to determine which medications will be most effective.